104 related articles for article (PubMed ID: 20379114)
1. [Marfan syndrome complicated with CD5+ CD10+ diffuse large B-cell lymphoma].
Yoshitake K; Hagiwara Y; Tanae K; Takahashi N; Kohri M; Tamaru J; Bessho M; Niitsu N
Rinsho Ketsueki; 2010 Mar; 51(3):196-200. PubMed ID: 20379114
[TBL] [Abstract][Full Text] [Related]
2. [Primary adrenal diffuse large B-cell lymphoma positive for CD5 and CD10].
Yamamoto Y; Sumii Y; Shiraishi Y; Ikeuchi K; Yamada H; Niiya D; Shiote Y; Yamamoto K; Imajo K
Rinsho Ketsueki; 2017; 58(2):161-164. PubMed ID: 28321095
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma.
Niitsu N; Okamoto M; Tamaru JI; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Hirano M
Ann Oncol; 2010 Oct; 21(10):2069-2074. PubMed ID: 20231297
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma.
Hyo R; Tomita N; Takeuchi K; Aoshima T; Fujita A; Kuwabara H; Hashimoto C; Takemura S; Taguchi J; Sakai R; Fujita H; Fujisawa S; Ogawa K; Motomura S; Suzuki R; Ishigatsubo Y
Hematol Oncol; 2010 Mar; 28(1):27-32. PubMed ID: 19358143
[TBL] [Abstract][Full Text] [Related]
5. Leukemic and meningeal relapse of CD5+ intravascular large B-cell lymphoma with down-modulation of CD20 after rituximab therapy.
Ohno T; Sakamoto T; Mizumoto C; Miyoshi T; Ueda M; Takeoka T; Yamashita K; Hishita T; Hada S
Int J Hematol; 2006 Jul; 84(1):74-8. PubMed ID: 16867907
[TBL] [Abstract][Full Text] [Related]
6. CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma.
Vassallo J; Bousquet M; Quelen C; Al Saati T; Delsol G; Brousset P
J Clin Pathol; 2007 May; 60(5):573-5. PubMed ID: 17513519
[TBL] [Abstract][Full Text] [Related]
7. Short-term efficacy of rituximab-CHOP and CHOP regimens on two subtypes of diffuse large B-cell lymphoma.
Xia Y; Li ZM; Shi YX; Xia ZJ; Jiang WQ; Huang HQ
Ai Zheng; 2009 Feb; 28(2):146-9. PubMed ID: 19550126
[TBL] [Abstract][Full Text] [Related]
8. Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas.
Manazza AD; Bonello L; Pagano M; Chiusa L; Novero D; Stacchini A; Martini G; Vitolo U; Tarella C; Inghirami G; Palestro G; Chiarle R
Am J Clin Pathol; 2005 Aug; 124(2):182-90. PubMed ID: 16040287
[TBL] [Abstract][Full Text] [Related]
9. [CD5- and CD10-positive MYC and BCL2 double-expressor diffuse large B-cell lymphoma with MYD88
Sasaki Y; Murai S; Okamura R; Uesugi Y; Shimada S; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Yanagisawa K; Honma M; Yamochi T; Hattori N
Rinsho Ketsueki; 2023; 64(1):42-48. PubMed ID: 36775306
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma. Identification of a high-risk subset with coexpression of CD10 and bcl-2.
Xu Y; McKenna RW; Molberg KH; Kroft SH
Am J Clin Pathol; 2001 Aug; 116(2):183-90. PubMed ID: 11488064
[TBL] [Abstract][Full Text] [Related]
11. [CD4-positive diffuse large B-cell lymphoma].
Nakazato T; Suzuki K; Mihara A; Sanada Y; Kakimoto T; Yoshida S
Rinsho Ketsueki; 2009 Jul; 50(7):568-73. PubMed ID: 19638725
[TBL] [Abstract][Full Text] [Related]
12. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma.
Yegappan S; Coupland R; Arber DA; Wang N; Miocinovic R; Tubbs RR; Hsi ED
Mod Pathol; 2001 Nov; 14(11):1147-56. PubMed ID: 11706077
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs.
Ueno S; Yamaguchi M; Kimura M; Odagiri H; Shiraki K; Uemoto S; Nakamura N; Zhang W; Shiku H; Kobayashi T
Int J Oncol; 2005 Nov; 27(5):1241-6. PubMed ID: 16211218
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 10 patients with de novo CD5 positive diffuse large B cell lymphoma].
Zhang Q; Zhang HY; Zhong FL; Zhang WL; Xu L; Feng J; Meng QX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):399-402. PubMed ID: 23628041
[TBL] [Abstract][Full Text] [Related]
15. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas.
Kobayashi T; Yamaguchi M; Kim S; Morikawa J; Ogawa S; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W
Cancer Res; 2003 Jan; 63(1):60-6. PubMed ID: 12517778
[TBL] [Abstract][Full Text] [Related]
16. [Richter syndrome: report of a case].
Chen DB; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):487-8. PubMed ID: 21055184
[No Abstract] [Full Text] [Related]
17. Rituximab regulates signaling pathways and alters gene expression associated with cell death and survival in diffuse large B-cell lymphoma.
Koivula S; Valo E; Raunio A; Hautaniemi S; Leppä S
Oncol Rep; 2011 Apr; 25(4):1183-90. PubMed ID: 21318224
[TBL] [Abstract][Full Text] [Related]
18. Rituximab alone was effective for the treatment of a diffuse large B-cell lymphoma associated with hemophagocytic syndrome.
Sano T; Sakai H; Takimoto K; Ohno H
Int J Clin Oncol; 2007 Feb; 12(1):59-62. PubMed ID: 17380444
[TBL] [Abstract][Full Text] [Related]
19. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M
Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]